MENU

PHAT Phathom Pharmaceuticals Forecast, Technical & Fundamental Analysis

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PHAT is expected to report earnings to fall ∞% to -6 cents per share on November 05

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q3'26
Est.
$-0.06
Q2'26
Beat
by $0.19
Q1'26
Beat
by $0.09
Q4'25
Beat
by $0.34
Q3'25
Beat
by $0.32
The last earnings report on July 30 showed earnings per share of 0 cents, beating the estimate of -18 cents. With 731.86K shares outstanding, the current market capitalization sits at 675.93M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
371
Web
https://www.phathompharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESMX15.570.13
+0.84%
First Eagle U.S. SMID Cap Opportunity I
OIEPX27.87N/A
N/A
JPMorgan Equity Income R3
FOKFX37.08N/A
N/A
Fidelity OTC K6
GTHCX17.96N/A
N/A
Invesco Health Care C
HSRUX30.10N/A
N/A
Carillon Eagle Small Cap Growth R6

PHAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with ALNY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-0.12%
ALNY - PHAT
43%
Loosely correlated
+0.47%
QCLS - PHAT
39%
Loosely correlated
+3.64%
ATRA - PHAT
36%
Loosely correlated
-5.16%
PROK - PHAT
30%
Poorly correlated
-2.17%
ORMP - PHAT
30%
Poorly correlated
-2.10%
More
Phathom Pharmaceuticals (PHAT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com